Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Immunol. 2021 Jul 6;12:681810. doi: 10.3389/fimmu.2021.681810. eCollection 2021.
Inflammation, which is induced by the immune response, is recognized as the driving factor in many diseases, including infections and inflammatory diseases, metabolic disorders and cancers. Genetic variations in pivotal genes associated with the immune response, particularly single nucleotide polymorphisms (SNPs), may account for predisposition and clinical outcome of diseases. Lipopolysaccharide (LPS)-binding protein (LBP) functions as an enhancer of the host response to LPS, the main component of the outer membrane of gram-native bacteria. Given the crucial role of LBP in inflammation, we will review the impact of SNPs in the gene on infections and inflammatory diseases, metabolic disorders and cancers.
炎症是由免疫反应引起的,被认为是许多疾病的驱动因素,包括感染和炎症性疾病、代谢紊乱和癌症。与免疫反应相关的关键基因中的遗传变异,特别是单核苷酸多态性(SNPs),可能导致疾病的易感性和临床结局。脂多糖(LPS)结合蛋白(LBP)作为宿主对 LPS(革兰氏阴性菌外膜的主要成分)反应的增强因子发挥作用。鉴于 LBP 在炎症中的关键作用,我们将综述基因中 SNPs 对感染和炎症性疾病、代谢紊乱和癌症的影响。